{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:54:01Z","timestamp":1791122041498,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11608-0","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:23:08Z","timestamp":1780572188000},"page":"7795-7809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TCM-based natural products in type 2 diabetes: a comprehensive review of bioactive compounds and molecular mechanisms"],"prefix":"10.1007","volume":"30","author":[{"given":"Yifeng","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"11608_CR1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/13880209.2024.2374794","volume":"62","author":"Y Ni","year":"2024","unstructured":"Ni Y, Wu X, Yao W et al (2024) Evidence of traditional Chinese medicine for treating type 2 diabetes mellitus: from molecular mechanisms to clinical efficacy. Pharm Biol 62:592\u2013606. https:\/\/doi.org\/10.1080\/13880209.2024.2374794","journal-title":"Pharm Biol"},{"key":"11608_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S2213-8587(25)00299-2","volume":"14","author":"I Genitsaridi","year":"2026","unstructured":"Genitsaridi I, Salpea P, Salim A et al (2026) 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. Lancet Diabetes Endocrinol 14:149\u2013156. https:\/\/doi.org\/10.1016\/S2213-8587(25)00299-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"11608_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1416403","volume":"15","author":"W Li","year":"2024","unstructured":"Li W, Liu X, Liu Z et al (2024) The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review. Front Pharmacol 15:1416403. https:\/\/doi.org\/10.3389\/fphar.2024.1416403","journal-title":"Front Pharmacol"},{"key":"11608_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154887","volume":"126","author":"X Cheng","year":"2024","unstructured":"Cheng X, Huang J, Li H et al (2024) Quercetin: a promising therapy for diabetic encephalopathy through inhibition of hippocampal ferroptosis. Phytomedicine 126:154887. https:\/\/doi.org\/10.1016\/j.phymed.2023.154887","journal-title":"Phytomedicine"},{"key":"11608_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/13880209.2025.2607563","volume":"64","author":"C Ge","year":"2026","unstructured":"Ge C, Shi Z, He J et al (2026) Cyanoglycosides isolated from Moringa oleifera seeds inhibited PFKFB3\/TGF-\u03b21\/smads pathway to alleviate diabetic nephropathy through driving metabolic reprogramming. Pharm Biol 64:130\u2013142. https:\/\/doi.org\/10.1080\/13880209.2025.2607563","journal-title":"Pharm Biol"},{"key":"11608_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2023.105862","volume":"110","author":"I Akhlaghipour","year":"2023","unstructured":"Akhlaghipour I, Nasimi Shad A, Askari VR et al (2023) How caffeic acid and its derivatives combat diabetes and its complications: a systematic review. J Funct Foods 110:105862. https:\/\/doi.org\/10.1016\/j.jff.2023.105862","journal-title":"J Funct Foods"},{"key":"11608_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120215","volume":"352","author":"SK Pattanaik","year":"2025","unstructured":"Pattanaik SK, Pattanaik S, Dash M et al (2025) Exploring anti-diabetic activity of Caryota mitis Lour. through modulation of PPAR- \u03b1\/\u03b3, GLUT-4, using in-vitro, in-vivo and in-silico approaches. J Ethnopharmacol 352:120215. https:\/\/doi.org\/10.1016\/j.jep.2025.120215","journal-title":"J Ethnopharmacol"},{"key":"11608_CR8","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.17179\/excli2023-6577","volume":"22","author":"A Mirzaei","year":"2023","unstructured":"Mirzaei A, Mirzaei A, Najjar Khalilabad S et al (2023) Promising influences of hesperidin and hesperetin against diabetes and its complications: a systematic review of molecular, cellular, and metabolic effects. EXCLI J 22:1235\u20131263. https:\/\/doi.org\/10.17179\/excli2023-6577","journal-title":"EXCLI J"},{"key":"11608_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.669448","author":"LT Marton","year":"2021","unstructured":"Marton LT, Pescinini-e-Salzedas LM, Camargo MEC et al (2021) The effects of curcumin on diabetes mellitus: a systematic review. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2021.669448","journal-title":"Front Endocrinol"},{"key":"11608_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1593780","author":"Y Liu","year":"2025","unstructured":"Liu Y, Ju Y, Wang Y et al (2025) Ginsenoside in the treatment of type 2 diabetes and its complications: a promising traditional Chinese medicine. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2025.1593780","journal-title":"Front Pharmacol"},{"key":"11608_CR11","doi-asserted-by":"publisher","first-page":"10121","DOI":"10.1039\/d2fo02300h","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, Chen C, Fu X (2022) Hypoglycemic effect of the polysaccharides from Astragalus membranaceus on type 2 diabetic mice based on the \u201cgut microbiota-mucosal barrier.\u201d Food Funct 13:10121\u201310133. https:\/\/doi.org\/10.1039\/d2fo02300h","journal-title":"Food Funct"},{"key":"11608_CR12","doi-asserted-by":"publisher","DOI":"10.26599\/FSHW.2024.9250007","volume":"14","author":"X Chen","year":"2025","unstructured":"Chen X, Chen C, Ma C et al (2025) Dendrobium officinale polysaccharide attenuates type 2 diabetes in mice model by modulating gut microbiota and alleviating intestinal mucosal barrier damage. Food Sci Hum Wellness 14:9250007. https:\/\/doi.org\/10.26599\/FSHW.2024.9250007","journal-title":"Food Sci Hum Wellness"},{"key":"11608_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27175573","volume":"27","author":"SSul Hassan","year":"2022","unstructured":"Hassan SSul, Abdel-Daim MM, Behl T, Bungau S (2022) Natural products for chronic diseases: a ray of hope. Molecules 27:5573. https:\/\/doi.org\/10.3390\/molecules27175573","journal-title":"Molecules"},{"key":"11608_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29204848","author":"Q Wu","year":"2024","unstructured":"Wu Q, Zhao D, Leng Y et al (2024) Identification of the hypoglycemic active components of Lonicera japonica Thunb. and Lonicera hypoglauca Miq. by UPLC-Q-TOF-MS. Molecules. https:\/\/doi.org\/10.3390\/molecules29204848","journal-title":"Molecules"},{"key":"11608_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ph18121890","author":"D Liu","year":"2025","unstructured":"Liu D, Zhao L, Wang Y et al (2025) Berberine: a rising star in the management of type 2 diabetes\u2014novel insights into its anti-inflammatory, metabolic, and epigenetic mechanisms. Pharmaceuticals. https:\/\/doi.org\/10.3390\/ph18121890","journal-title":"Pharmaceuticals"},{"key":"11608_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.prmcm.2025.100689","volume":"17","author":"KC Mbara","year":"2025","unstructured":"Mbara KC, Kheoane PS, Tarirai C (2025) Targeting AMPK signaling: the therapeutic potential of berberine in diabetes and its complications. Pharmacol Res Mod Chin Med 17:100689. https:\/\/doi.org\/10.1016\/j.prmcm.2025.100689","journal-title":"Pharmacol Res Mod Chin Med"},{"key":"11608_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00557","volume":"9","author":"MA Neag","year":"2018","unstructured":"Neag MA, Mocan A, Echeverr\u00eda J et al (2018) Berberine: botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Front Pharmacol 9:557. https:\/\/doi.org\/10.3389\/fphar.2018.00557","journal-title":"Front Pharmacol"},{"key":"11608_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110984","volume":"133","author":"X Xu","year":"2021","unstructured":"Xu X, Yi H, Wu J et al (2021) Therapeutic effect of berberine on metabolic diseases: both pharmacological data and clinical evidence. Biomed Pharmacother 133:110984. https:\/\/doi.org\/10.1016\/j.biopha.2020.110984","journal-title":"Biomed Pharmacother"},{"key":"11608_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biology12070973","author":"AR Utami","year":"2023","unstructured":"Utami AR, Maksum IP, Deawati Y (2023) Berberine and its study as an antidiabetic compound. Biology. https:\/\/doi.org\/10.3390\/biology12070973","journal-title":"Biology"},{"key":"11608_CR20","first-page":"338","volume":"83","author":"L Zhou","year":"2003","unstructured":"Zhou L, Chen M, Wang X et al (2003) Effect of berberine on the differentiation of adipocyte. Zhonghua Yi Xue Za Zhi 83:338\u2013340","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"11608_CR21","doi-asserted-by":"publisher","first-page":"E148","DOI":"10.1152\/ajpendo.00211.2007","volume":"294","author":"J Yin","year":"2008","unstructured":"Yin J, Gao Z, Liu D et al (2008) Berberine improves glucose metabolism through induction of glycolysis. Am J Physiol Endocrinol Metab 294:E148\u2013E156. https:\/\/doi.org\/10.1152\/ajpendo.00211.2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"11608_CR22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ejphar.2015.07.040","volume":"764","author":"W-J Ni","year":"2015","unstructured":"Ni W-J, Ding H-H, Zhou H et al (2015) Renoprotective effects of berberine through regulation of the MMPs\/TIMPs system in streptozocin-induced diabetic nephropathy in rats. Eur J Pharmacol 764:448\u2013456. https:\/\/doi.org\/10.1016\/j.ejphar.2015.07.040","journal-title":"Eur J Pharmacol"},{"key":"11608_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cells8060632","author":"Y-C Lin","year":"2019","unstructured":"Lin Y-C, Lee Y-C, Lin Y-J, Lin J-C (2019) Berberine promotes beige adipogenic signatures of 3T3-L1 cells by regulating post-transcriptional events. Cells. https:\/\/doi.org\/10.3390\/cells8060632","journal-title":"Cells"},{"key":"11608_CR24","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/ptr.6588","volume":"34","author":"C-N Li","year":"2020","unstructured":"Li C-N, Wang X, Lei L et al (2020) Berberine combined with stachyose induces better glycometabolism than berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice. Phytother Res 34:1166\u20131174. https:\/\/doi.org\/10.1002\/ptr.6588","journal-title":"Phytother Res"},{"key":"11608_CR25","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1039\/d0ob00327a","volume":"18","author":"L Wang","year":"2020","unstructured":"Wang L, Kong H, Jin M et al (2020) Synthesis of disaccharide modified berberine derivatives and their anti-diabetic investigation in zebrafish using a fluorescence-based technology. Org Biomol Chem 18:3563\u20133574. https:\/\/doi.org\/10.1039\/d0ob00327a","journal-title":"Org Biomol Chem"},{"key":"11608_CR26","doi-asserted-by":"publisher","first-page":"9813","DOI":"10.1021\/acsomega.3c10232","volume":"9","author":"M Alamzeb","year":"2024","unstructured":"Alamzeb M, Shah SWA, Hussain H et al (2024) Beneficial effects of natural alkaloids from Berberis glaucocarpa as antidiabetic agents: an in vitro, in silico, and in vivo approach. ACS Omega 9:9813\u20139822. https:\/\/doi.org\/10.1021\/acsomega.3c10232","journal-title":"ACS Omega"},{"key":"11608_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18414-8","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Gu Y, Ren H et al (2020) Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun 11:5015. https:\/\/doi.org\/10.1038\/s41467-020-18414-8","journal-title":"Nat Commun"},{"key":"11608_CR28","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1055\/s-2003-41121","volume":"69","author":"G-Y Pan","year":"2003","unstructured":"Pan G-Y, Huang Z-J, Wang G-J et al (2003) The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Med 69:632\u2013636. https:\/\/doi.org\/10.1055\/s-2003-41121","journal-title":"Planta Med"},{"key":"11608_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25701-5","volume":"12","author":"SA Harrison","year":"2021","unstructured":"Harrison SA, Gunn N, Neff GW et al (2021) A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes. Nat Commun 12:5503. https:\/\/doi.org\/10.1038\/s41467-021-25701-5","journal-title":"Nat Commun"},{"key":"11608_CR30","doi-asserted-by":"publisher","first-page":"7681","DOI":"10.2147\/DDDT.S531909","volume":"19","author":"B Song","year":"2025","unstructured":"Song B, Yue D, Yan H et al (2025) Traditional Chinese medicine natural products targeting shared mechanisms of T2DM and AD: potential therapeutic insights. Drug Des Devel Ther 19:7681\u20137705. https:\/\/doi.org\/10.2147\/DDDT.S531909","journal-title":"Drug Des Devel Ther"},{"key":"11608_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-025-04872-4","volume":"25","author":"L Shi","year":"2025","unstructured":"Shi L, Wang W, Jing C et al (2025) Berberine and health outcomes: an overview of systematic reviews. BMC Complement Med Ther 25:147. https:\/\/doi.org\/10.1186\/s12906-025-04872-4","journal-title":"BMC Complement Med Ther"},{"key":"11608_CR32","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.2147\/DMSO.S517874","volume":"18","author":"S Wen","year":"2025","unstructured":"Wen S, Zhang H, Huang X et al (2025) The therapeutic effect and mechanism of traditional Chinese medicine in type 2 diabetes mellitus and its complications. Diabetes Metab Syndr Obes 18:1599\u20131627. https:\/\/doi.org\/10.2147\/DMSO.S517874","journal-title":"Diabetes Metab Syndr Obes"},{"key":"11608_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1549462","volume":"16","author":"Z Fan","year":"2025","unstructured":"Fan Z, Wei X, Zhu X et al (2025) Unveiling the therapeutic potential of berberine: its therapeutic role and molecular mechanisms in kidney diseases. Front Pharmacol 16:1549462. https:\/\/doi.org\/10.3389\/fphar.2025.1549462","journal-title":"Front Pharmacol"},{"key":"11608_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","volume":"15","author":"SC Gupta","year":"2013","unstructured":"Gupta SC, Patchva S, Aggarwal BB (2013) Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 15:195\u2013218. https:\/\/doi.org\/10.1208\/s12248-012-9432-8","journal-title":"AAPS J"},{"key":"11608_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1189034","volume":"2022","author":"M Ayaz","year":"2022","unstructured":"Ayaz M, Nawaz A, Ahmad S et al (2022) Underlying anticancer mechanisms and synergistic combinations of phytochemicals with cancer chemotherapeutics: potential benefits and risks. J Food Qual 2022:1189034. https:\/\/doi.org\/10.1155\/2022\/1189034","journal-title":"J Food Qual"},{"key":"11608_CR36","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1021\/acs.jafc.7b01792","volume":"65","author":"H Yang","year":"2017","unstructured":"Yang H, Du Z, Wang W et al (2017) Structure-activity relationship of Curcumin: role of the methoxy group in anti-inflammatory and anticolitis effects of Curcumin. J Agric Food Chem 65:4509\u20134515. https:\/\/doi.org\/10.1021\/acs.jafc.7b01792","journal-title":"J Agric Food Chem"},{"key":"11608_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.14358","volume":"46","author":"W Lu","year":"2022","unstructured":"Lu W, Khatibi Shahidi F, Khorsandi K et al (2022) An update on molecular mechanisms of curcumin effect on diabetes. J Food Biochem 46:e14358. https:\/\/doi.org\/10.1111\/jfbc.14358","journal-title":"J Food Biochem"},{"key":"11608_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27134058","author":"Y Hussain","year":"2022","unstructured":"Hussain Y, Khan H, Alotaibi G et al (2022) How curcumin targets inflammatory mediators in diabetes: therapeutic insights and possible solutions. Molecules. https:\/\/doi.org\/10.3390\/molecules27134058","journal-title":"Molecules"},{"key":"11608_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/ars.2008.2140","volume":"11","author":"SK Jain","year":"2009","unstructured":"Jain SK, Rains J, Croad J et al (2009) Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal 11:241\u2013249. https:\/\/doi.org\/10.1089\/ars.2008.2140","journal-title":"Antioxid Redox Signal"},{"key":"11608_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/aps.2017.92","volume":"39","author":"S Guo","year":"2018","unstructured":"Guo S, Meng X, Yang X et al (2018) Curcumin administration suppresses collagen synthesis in the hearts of rats with experimental diabetes. Acta Pharmacol Sin 39:195\u2013204. https:\/\/doi.org\/10.1038\/aps.2017.92","journal-title":"Acta Pharmacol Sin"},{"key":"11608_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4158591","volume":"2016","author":"W Yu","year":"2016","unstructured":"Yu W, Zha W, Ke Z et al (2016) Curcumin protects neonatal rat cardiomyocytes against high glucose-induced apoptosis via PI3K\/Akt signalling pathway. J Diabetes Res 2016:4158591. https:\/\/doi.org\/10.1155\/2016\/4158591","journal-title":"J Diabetes Res"},{"key":"11608_CR42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/jbt.21562","volume":"28","author":"OM Abo-Salem","year":"2014","unstructured":"Abo-Salem OM, Harisa GI, Ali TM et al (2014) Curcumin ameliorates streptozotocin-induced heart injury in rats. J Biochem Mol Toxicol 28:263\u2013270. https:\/\/doi.org\/10.1002\/jbt.21562","journal-title":"J Biochem Mol Toxicol"},{"key":"11608_CR43","doi-asserted-by":"publisher","first-page":"E1239","DOI":"10.1152\/ajpendo.00629.2013","volume":"306","author":"Y Wang","year":"2014","unstructured":"Wang Y, Zhou S, Sun W et al (2014) Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression. Am J Physiol Endocrinol Metab 306:E1239\u2013E1247. https:\/\/doi.org\/10.1152\/ajpendo.00629.2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"11608_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13098-019-0437-7","volume":"11","author":"H Hodaei","year":"2019","unstructured":"Hodaei H, Adibian M, Nikpayam O et al (2019) The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial. Diabetol Metab Syndr 11:41. https:\/\/doi.org\/10.1186\/s13098-019-0437-7","journal-title":"Diabetol Metab Syndr"},{"key":"11608_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28103996","author":"R Naz","year":"2023","unstructured":"Naz R, Saqib F, Awadallah S et al (2023) Food polyphenols and type II diabetes mellitus: pharmacology and mechanisms. Molecules. https:\/\/doi.org\/10.3390\/molecules28103996","journal-title":"Molecules"},{"key":"11608_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00472","volume":"9","author":"J Zheng","year":"2018","unstructured":"Zheng J, Cheng J, Zheng S et al (2018) Curcumin, a polyphenolic curcuminoid with its protective effects and molecular mechanisms in diabetes and diabetic cardiomyopathy. Front Pharmacol 9:472. https:\/\/doi.org\/10.3389\/fphar.2018.00472","journal-title":"Front Pharmacol"},{"key":"11608_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12986-019-0331-1","volume":"16","author":"SA Jazayeri-Tehrani","year":"2019","unstructured":"Jazayeri-Tehrani SA, Rezayat SM, Mansouri S et al (2019) Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial. Nutr Metab 16:8. https:\/\/doi.org\/10.1186\/s12986-019-0331-1","journal-title":"Nutr Metab"},{"key":"11608_CR48","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ctim.2019.02.014","volume":"43","author":"S Asadi","year":"2019","unstructured":"Asadi S, Gholami MS, Siassi F et al (2019) Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: a randomized double-blind placebo- controlled clinical trial. Complement Ther Med 43:253\u2013260. https:\/\/doi.org\/10.1016\/j.ctim.2019.02.014","journal-title":"Complement Ther Med"},{"key":"11608_CR49","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1002\/ptr.7109","volume":"35","author":"Z Bateni","year":"2021","unstructured":"Bateni Z, Rahimi HR, Hedayati M et al (2021) The effects of nano-curcumin supplementation on glycemic control, blood pressure, lipid profile, and insulin resistance in patients with the metabolic syndrome: a randomized, double-blind clinical trial. Phytother Res 35:3945\u20133953. https:\/\/doi.org\/10.1002\/ptr.7109","journal-title":"Phytother Res"},{"key":"11608_CR50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.joim.2018.07.001","volume":"16","author":"R Jamwal","year":"2018","unstructured":"Jamwal R (2018) Bioavailable curcumin formulations: a review of pharmacokinetic studies in healthy volunteers. J Integr Med 16:367\u2013374. https:\/\/doi.org\/10.1016\/j.joim.2018.07.001","journal-title":"J Integr Med"},{"key":"11608_CR51","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1007\/s10753-018-0823-6","volume":"41","author":"J Yuan","year":"2018","unstructured":"Yuan J, Liu R, Ma Y et al (2018) Curcumin attenuates airway inflammation and airway remolding by inhibiting NF-\u03baB signaling and COX-2 in cigarette smoke-induced COPD mice. Inflammation 41:1804\u20131814. https:\/\/doi.org\/10.1007\/s10753-018-0823-6","journal-title":"Inflammation"},{"key":"11608_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9111092","author":"K Jakubczyk","year":"2020","unstructured":"Jakubczyk K, Dru\u017cga A, Katarzyna J, Skonieczna-\u017bydecka K (2020) Antioxidant potential of curcumin-a meta-analysis of randomized clinical trials. Antioxidants. https:\/\/doi.org\/10.3390\/antiox9111092","journal-title":"Antioxidants"},{"key":"11608_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21050603","author":"H-P Wang","year":"2016","unstructured":"Wang H-P, Zhang Y-B, Yang X-W et al (2016) High-performance liquid chromatography with diode array detector and electrospray ionization ion trap time-of-flight tandem mass spectrometry to evaluate ginseng roots and rhizomes from different regions. Molecules. https:\/\/doi.org\/10.3390\/molecules21050603","journal-title":"Molecules"},{"key":"11608_CR54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.phytochem.2014.07.012","volume":"106","author":"W Yang","year":"2014","unstructured":"Yang W, Hu Y, Wu W et al (2014) Saponins in the genus Panax L. (Araliaceae): a systematic review of their chemical diversity. Phytochemistry 106:7\u201324. https:\/\/doi.org\/10.1016\/j.phytochem.2014.07.012","journal-title":"Phytochemistry"},{"key":"11608_CR55","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jgr.2020.02.004","volume":"45","author":"ZA Ratan","year":"2021","unstructured":"Ratan ZA, Haidere MF, Hong YH et al (2021) Pharmacological potential of ginseng and its major component ginsenosides. J Ginseng Res 45:199\u2013210. https:\/\/doi.org\/10.1016\/j.jgr.2020.02.004","journal-title":"J Ginseng Res"},{"key":"11608_CR56","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jgr.2016.12.013","volume":"42","author":"D Lee","year":"2018","unstructured":"Lee D, Lee D-S, Jung K et al (2018) Protective effect of ginsenoside Rb1 against tacrolimus-induced apoptosis in renal proximal tubular LLC-PK1 cells. J Ginseng Res 42:75\u201380. https:\/\/doi.org\/10.1016\/j.jgr.2016.12.013","journal-title":"J Ginseng Res"},{"key":"11608_CR57","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jgr.2017.03.011","volume":"42","author":"KH Kim","year":"2018","unstructured":"Kim KH, Lee D, Lee HL et al (2018) Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: past findings and future directions. J Ginseng Res 42:239\u2013247. https:\/\/doi.org\/10.1016\/j.jgr.2017.03.011","journal-title":"J Ginseng Res"},{"key":"11608_CR58","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1002\/ptr.8229","volume":"38","author":"L Zhang","year":"2024","unstructured":"Zhang L, He S, Liu L, Huang J (2024) Saponin monomers: potential candidates for the treatment of type 2 diabetes mellitus and its complications. Phyther Res 38:3564\u20133582. https:\/\/doi.org\/10.1002\/ptr.8229","journal-title":"Phyther Res"},{"key":"11608_CR59","doi-asserted-by":"publisher","first-page":"47353","DOI":"10.1039\/C5RA05864C","volume":"5","author":"K-K Li","year":"2015","unstructured":"Li K-K, Gong X-J (2015) A review on the medicinal potential of Panax ginseng saponins in diabetes mellitus. RSC Adv 5:47353\u201347366. https:\/\/doi.org\/10.1039\/C5RA05864C","journal-title":"RSC Adv"},{"key":"11608_CR60","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3389\/fphar.2018.00423","volume":"9","author":"L Bai","year":"2018","unstructured":"Bai L, Gao J, Wei F et al (2018) Therapeutic potential of ginsenosides as an adjuvant treatment for diabetes. Front Pharmacol 9:423. https:\/\/doi.org\/10.3389\/fphar.2018.00423","journal-title":"Front Pharmacol"},{"key":"11608_CR61","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ejphar.2008.06.077","volume":"591","author":"KS Kang","year":"2008","unstructured":"Kang KS, Yamabe N, Kim HY et al (2008) Therapeutic potential of 20(S)-ginsenoside Rg(3) against streptozotocin-induced diabetic renal damage in rats. Eur J Pharmacol 591:266\u2013272. https:\/\/doi.org\/10.1016\/j.ejphar.2008.06.077","journal-title":"Eur J Pharmacol"},{"key":"11608_CR62","doi-asserted-by":"publisher","first-page":"8491","DOI":"10.1021\/jf071770y","volume":"55","author":"HY Kim","year":"2007","unstructured":"Kim HY, Kang KS, Yamabe N et al (2007) Protective effect of heat-processed American ginseng against diabetic renal damage in rats. J Agric Food Chem 55:8491\u20138497. https:\/\/doi.org\/10.1021\/jf071770y","journal-title":"J Agric Food Chem"},{"key":"11608_CR63","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1248\/bpb.29.1678","volume":"29","author":"KS Kang","year":"2006","unstructured":"Kang KS, Kim HY, Yamabe N et al (2006) Protective effect of sun ginseng against diabetic renal damage. Biol Pharm Bull 29:1678\u20131684. https:\/\/doi.org\/10.1248\/bpb.29.1678","journal-title":"Biol Pharm Bull"},{"key":"11608_CR64","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1248\/bpb.33.1077","volume":"33","author":"KS Kang","year":"2010","unstructured":"Kang KS, Yamabe N, Kim HY et al (2010) Effects of heat-processed ginseng and its active component ginsenoside 20(S)-Rg3 on the progression of renal damage and dysfunction in type 2 diabetic Otsuka Long-Evans Tokushima Fatty rats. Biol Pharm Bull 33:1077\u20131081. https:\/\/doi.org\/10.1248\/bpb.33.1077","journal-title":"Biol Pharm Bull"},{"key":"11608_CR65","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3346\/jkms.2011.26.10.1316","volume":"26","author":"T-S Ha","year":"2011","unstructured":"Ha T-S, Choi J-Y, Park H-Y, Lee J-S (2011) Ginseng total saponin improves podocyte hyperpermeability induced by high glucose and advanced glycosylation endproducts. J Korean Med Sci 26:1316\u20131321. https:\/\/doi.org\/10.3346\/jkms.2011.26.10.1316","journal-title":"J Korean Med Sci"},{"key":"11608_CR66","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ptr.2297","volume":"22","author":"M Xi","year":"2008","unstructured":"Xi M, Hai C, Tang H et al (2008) Antioxidant and antiglycation properties of total saponins extracted from traditional Chinese medicine used to treat diabetes mellitus. Phytother Res 22:228\u2013237. https:\/\/doi.org\/10.1002\/ptr.2297","journal-title":"Phytother Res"},{"key":"11608_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jafr.2025.102198","volume":"23","author":"L-H Han","year":"2025","unstructured":"Han L-H, Jin M, Qi X et al (2025) Ginseng flower total saponin extract alleviates type 1 diabetes mellitus-associated liver injury via PI3K\/AKT\/HIF-1\u03b1 signaling pathway. J Agric Food Res 23:102198. https:\/\/doi.org\/10.1016\/j.jafr.2025.102198","journal-title":"J Agric Food Res"},{"key":"11608_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1373711","volume":"15","author":"Y Feng","year":"2024","unstructured":"Feng Y, Ren Y, Zhang X et al (2024) Metabolites of traditional Chinese medicine targeting PI3K\/AKT signaling pathway for hypoglycemic effect in type 2 diabetes. Front Pharmacol 15:1373711. https:\/\/doi.org\/10.3389\/fphar.2024.1373711","journal-title":"Front Pharmacol"},{"key":"11608_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1584035","volume":"16","author":"B Xiong","year":"2025","unstructured":"Xiong B, Wang H, Song Y-X et al (2025) Natural saponins and macrophage polarization: mechanistic insights and therapeutic perspectives in disease management. Front Pharmacol 16:1584035. https:\/\/doi.org\/10.3389\/fphar.2025.1584035","journal-title":"Front Pharmacol"},{"key":"11608_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28581","volume":"10","author":"S Liu","year":"2024","unstructured":"Liu S, Wang M, Xiao H et al (2024) Advancements in research on the effects of Panax notoginseng saponin constituents in ameliorating learning and memory disorders. Heliyon 10:e28581. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28581","journal-title":"Heliyon"},{"key":"11608_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154099","volume":"101","author":"Y Lyu","year":"2022","unstructured":"Lyu Y, Li D, Yuan X et al (2022) Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db\/db mice. Phytomedicine 101:154099. https:\/\/doi.org\/10.1016\/j.phymed.2022.154099","journal-title":"Phytomedicine"},{"key":"11608_CR72","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1677\/JOE-08-0104","volume":"198","author":"W Shang","year":"2008","unstructured":"Shang W, Yang Y, Zhou L et al (2008) Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes. J Endocrinol 198:561\u2013569. https:\/\/doi.org\/10.1677\/JOE-08-0104","journal-title":"J Endocrinol"},{"key":"11608_CR73","doi-asserted-by":"publisher","first-page":"934","DOI":"10.2174\/157340612802084199","volume":"8","author":"QT Bu","year":"2012","unstructured":"Bu QT, Zhang WY, Chen QC et al (2012) Anti-diabetic effect of ginsenoside Rb3 in alloxan-induced diabetic mice. Med Chem 8:934\u2013941. https:\/\/doi.org\/10.2174\/157340612802084199","journal-title":"Med Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11608-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11608-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11608-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:47:31Z","timestamp":1791121651000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11608-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":73,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["11608"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11608-0","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final manuscript for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}